These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30972039)
41. Molecular and cellular biology of von Willebrand factor. Denis CV Int J Hematol; 2002 Jan; 75(1):3-8. PubMed ID: 11843287 [TBL] [Abstract][Full Text] [Related]
42. Thrombospondin-1 in von Willebrand factor function. Bonnefoy A; Hoylaerts MF Curr Drug Targets; 2008 Oct; 9(10):822-32. PubMed ID: 18855616 [TBL] [Abstract][Full Text] [Related]
43. Correlative light microscopy and electron tomography to study Von Willebrand factor exocytosis from vascular endothelial cells. Mourik MJ; Faas FG; Valentijn KM; Valentijn JA; Eikenboom JC; Koster AJ Methods Cell Biol; 2014; 124():71-92. PubMed ID: 25287837 [TBL] [Abstract][Full Text] [Related]
44. Identification of peptide antagonists to glycoprotein Ibalpha that selectively inhibit von Willebrand factor dependent platelet aggregation. Benard SA; Smith TM; Cunningham K; Jacob J; DeSilva T; Lin L; Shaw GD; Kriz R; Kelleher KS Biochemistry; 2008 Apr; 47(16):4674-82. PubMed ID: 18363340 [TBL] [Abstract][Full Text] [Related]
45. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa. Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012 [TBL] [Abstract][Full Text] [Related]
46. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor. Jones TR; Kao KJ; Pizzo SV; Bigner DD Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103 [TBL] [Abstract][Full Text] [Related]
47. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Denis CV; André P; Saffaripour S; Wagner DD Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4072-7. PubMed ID: 11274431 [TBL] [Abstract][Full Text] [Related]
48. Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation. López JA; Dong JF Blood Coagul Fibrinolysis; 2005 Apr; 16 Suppl 1():S11-6. PubMed ID: 15849521 [TBL] [Abstract][Full Text] [Related]
49. Type I von Willebrand disease, subtype 'platelet low': decreased platelet adhesion can be explained by low synthesis of von Willebrand factor in endothelial cells. Federici AB; de Groot PG; Moia M; Ijsseldijk MJ; Sixma JJ; Mannucci PM Br J Haematol; 1993 Jan; 83(1):88-93. PubMed ID: 8435340 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor. Andrews RK; Bendall LJ; Booth WJ; Berndt MC Platelets; 1995; 6(5):252-8. PubMed ID: 21043709 [TBL] [Abstract][Full Text] [Related]
52. Von Willebrand Factor Facilitates Intravascular Dissemination of Microsporidia Bao J; Mo B; An G; Luo J; Poncz M; Pan G; Li T; Zhou Z Front Cell Infect Microbiol; 2021; 11():694957. PubMed ID: 34095003 [TBL] [Abstract][Full Text] [Related]
59. Deciphering the triad of endothelial glycocalyx, von Willebrand Factor, and P-selectin in inflammation-induced coagulation. Ferreira G; Taylor A; Mensah SA Front Cell Dev Biol; 2024; 12():1372355. PubMed ID: 38745860 [TBL] [Abstract][Full Text] [Related]
60. Impact of Von Willebrand Factor on Bacterial Pathogenesis. Steinert M; Ramming I; Bergmann S Front Med (Lausanne); 2020; 7():543. PubMed ID: 33015097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]